These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22952043)

  • 1. Generalized anxiety disorder and the proposed associated symptoms criterion change for DSM-5 in a treatment-seeking sample of anxious youth.
    Comer JS; Pincus DB; Hofmann SG
    Depress Anxiety; 2012 Dec; 29(12):994-1003. PubMed ID: 22952043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specifying child anxiety disorders not otherwise specified in the DSM-IV.
    Comer JS; Gallo KP; Korathu-Larson P; Pincus DB; Brown TA
    Depress Anxiety; 2012 Dec; 29(12):1004-13. PubMed ID: 22807226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficulty concentrating in generalized anxiety disorder: An evaluation of incremental utility and relationship to worry.
    Hallion LS; Steinman SA; Kusmierski SN
    J Anxiety Disord; 2018 Jan; 53():39-45. PubMed ID: 29175616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview and clinical presentation of generalized anxiety disorder.
    Rickels K; Rynn M
    Psychiatr Clin North Am; 2001 Mar; 24(1):1-17. PubMed ID: 11225502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic symptoms of generalized anxiety disorder from the DSM-IV: associations with pathological worry and depression symptoms in a nonclinical sample.
    Joormann J; Stöber J
    J Anxiety Disord; 1999; 13(5):491-503. PubMed ID: 10600050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the threshold of disorder: a study of the impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice.
    Zimmerman M; Chelminski I; Young D
    J Clin Psychiatry; 2004 Oct; 65(10):1400-5. PubMed ID: 15491245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the proposed social anxiety disorder specifier change for DSM-5 in a treatment-seeking sample of anxious youth.
    Kerns CE; Comer JS; Pincus DB; Hofmann SG
    Depress Anxiety; 2013 Aug; 30(8):709-15. PubMed ID: 23494954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construct of generalized anxiety disorder in Alzheimer disease.
    Starkstein SE; Jorge R; Petracca G; Robinson RG
    Am J Geriatr Psychiatry; 2007 Jan; 15(1):42-9. PubMed ID: 17194814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the draft DSM-5 criteria for GAD on prevalence and severity.
    Andrews G; Hobbs MJ
    Aust N Z J Psychiatry; 2010 Sep; 44(9):784-90. PubMed ID: 20815664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of generalized anxiety disorder in patients with dementia.
    Calleo JS; Kunik ME; Reid D; Kraus-Schuman C; Paukert A; Regev T; Wilson N; Petersen NJ; Snow AL; Stanley M
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):492-7. PubMed ID: 22062223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
    Pollack MH; Meoni P; Otto MW; Simon N; Hackett D
    J Clin Psychopharmacol; 2003 Jun; 23(3):250-9. PubMed ID: 12826987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The history of generalized anxiety disorder as a diagnostic category.
    Crocq MA
    Dialogues Clin Neurosci; 2017 Jun; 19(2):107-116. PubMed ID: 28867935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well.
    Wetherell JL; Le Roux H; Gatz M
    Psychol Aging; 2003 Sep; 18(3):622-7. PubMed ID: 14518822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLINICAL CONSEQUENCES OF THE REVISED DSM-5 DEFINITION OF AGORAPHOBIA IN TREATMENT-SEEKING ANXIOUS YOUTH.
    Cornacchio D; Chou T; Sacks H; Pincus D; Comer J
    Depress Anxiety; 2015 Jul; 32(7):502-8. PubMed ID: 25845579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity and specificity of the worry and anxiety questionnaire (WAQ) in a sample of health-care users in the province of Quebec].
    Belleville G; Bélanger L; Ladouceur R; Morin CM
    Encephale; 2008 Jun; 34(3):240-8. PubMed ID: 18558144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability.
    Slade T; Andrews G
    Soc Psychiatry Psychiatr Epidemiol; 2001 Jan; 36(1):45-51. PubMed ID: 11320807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication.
    Ruscio AM; Lane M; Roy-Byrne P; Stang PE; Stein DJ; Wittchen HU; Kessler RC
    Psychol Med; 2005 Dec; 35(12):1761-72. PubMed ID: 16300690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficiency of symptoms in the diagnosis of DSM-IV: generalized anxiety disorder in youth.
    Pina AA; Silverman WK; Alfano CA; Saavedra LM
    J Child Psychol Psychiatry; 2002 Oct; 43(7):959-67. PubMed ID: 12405483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delimiting the boundaries of generalized anxiety disorder: differentiating high worriers with and without GAD.
    Ruscio AM
    J Anxiety Disord; 2002; 16(4):377-400. PubMed ID: 12213034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of generalized anxiety disorder.
    Kessler RC; Keller MB; Wittchen HU
    Psychiatr Clin North Am; 2001 Mar; 24(1):19-39. PubMed ID: 11225507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.